Levomethadon Neuraxpharm (Levomethadone Hydrochloride)

Levomethadone acts as a full agonist at the µ‑opioid receptors in the central nervous system. By binding to these receptors, it activates inhibitory G‑protein pathways, which reduces neuronal excitability, diminishes the transmission of pain signals, and modulates the reward circuitry involved in opioid dependence, thereby providing analgesia and easing withdrawal symptoms.

The specific dose of Levomethadon Neuraxpharm is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Healthcare professionals adjust the dosage to achieve the desired therapeutic effect while minimizing adverse reactions.

Safety data for levomethadone during pregnancy and lactation are limited. Because opioids can cross the placenta and may be excreted in breast milk, the drug should only be used when the potential benefit justifies the potential risk to the fetus or infant. Clinicians should evaluate each case carefully and consider alternative therapies when appropriate.

To request Levomethadon Neuraxpharm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Levomethadon is the levo‑isomer of methadone and generally offers similar analgesic potency with a potentially more favorable side‑effect profile. Compared with buprenorphine, levomethadone is a full µ‑opioid agonist, which may provide stronger analgesia but also carries a higher risk of respiratory depression. Choice of therapy depends on patient-specific factors, treatment goals and safety considerations.

Store Levomethadon Neuraxpharm at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date indicated on the label.

Levomethadon Neuraxpharm is administered orally, typically as a tablet or capsule taken with water. The exact route (e.g., with or without food) and dosing schedule should follow the prescribing clinician’s instructions to ensure optimal absorption and therapeutic effect.

The most serious risks include respiratory depression, severe hypotension, cardiac arrhythmias, and the potential for dependence or abuse. Patients should be monitored closely for signs of slowed breathing, low blood pressure, or irregular heart rhythm, especially when initiating therapy or when combined with other central nervous system depressants.

Levomethadon Neuraxpharm is contraindicated in individuals with known hypersensitivity to levomethadone or other opioids, patients with severe respiratory insufficiency, acute asthma attacks, or paralytic ileus. It should also be avoided in patients taking monoamine oxidase inhibitors within 14 days of therapy due to the risk of serious drug interactions.